Selection of indicators reporting response rate in pharmaceutical trials for systemic lupus erythematosus: preference and relative sensitivity

OBJECTIVE: SLE is a common multisystem autoimmune disease with chronic inflammation. Many efficacy evaluation indicators of randomised clinical trials (RCTs) for SLE have been proposed but the comparability remains unknown. We aim to explore the preference and comparability of indicators reporting r...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Jingru, Kang, Shuntong, Zhang, Dingyao, Huang, Yaqing, Yao, Xu, Zhao, Ming, Lu, Qianjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Epidemiology and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565300/
https://www.ncbi.nlm.nih.gov/pubmed/37798046
http://dx.doi.org/10.1136/lupus-2023-000942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565300/
https://www.ncbi.nlm.nih.gov/pubmed/37798046
http://dx.doi.org/10.1136/lupus-2023-000942

Ejemplares similares